Trial Profile
Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Substance withdrawal syndrome
- Focus Adverse reactions; Therapeutic Use
- 14 May 2014 New trial record